Partnering with the South African Department of Health to Enhance Public Healthcare

One of Aspen’s key business imperatives is the creation… 继续阅读Partnering with the South African Department of Health to Enhance Public Healthcare

Aspen cleared of alleged anti-competitive behavior by DA

Durban – JSE Limited-listed Aspen Pharmacare (APN… 继续阅读Aspen cleared of alleged anti-competitive behavior by DA

Aspen concludes strategic M.O.U with the Russian Federation

Windhoek, Namibia – JSE Limited listed Aspen Phar… 继续阅读Aspen concludes strategic M.O.U with the Russian Federation

Statement in response to The Times of London report on 20 May 2017 on Florinef

Having noted the report published in The Times of Londo… 继续阅读Statement in response to The Times of London report on 20 May 2017 on Florinef

Opening of European Commission proceedings

Aspen confirms that the European Commission has opened … 继续阅读Opening of European Commission proceedings

Aspen’s response to the reported Competition Commission investigation

Durban – Media reports that the Competition Commi… 继续阅读Aspen’s response to the reported Competition Commission investigation

Statement in response to press reports of 14 and 15 April 2017

In reference to the articles reported in the European p… 继续阅读Statement in response to press reports of 14 and 15 April 2017

Honouring Ahmed M Kathrada

This morning we wake up to the news, that one of the co… 继续阅读Honouring Ahmed M Kathrada

Closed Period

Aspen is in a closed period from 1 January until the publication of our interim results on the JSE SENS platform scheduled to be released on 1 March 2023.

The live presentation will take place in Cape Town at 08h30 on 2 March 2023.